PATENT CLAIM ANALYSIS

Application Number: 15918489
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["435", "007100"]

Abstract:
Disclosed are systems and methods for developing diagnostic tests (e.g., detection, screening, monitoring, and prognostic tests) based on biomarker information from legacy clinical sample sets, for which only small sample volumes (e.g., about 0.05 to about 1.0 mL or less per sample) are typically available. For example, biomarkers (e.g., about 10, 50, 100, 150, 200, 300, or more) may be detected in the clinical samples through the use of single molecule detection and each biomarker may be detected in an assay that includes about 1 or less of a legacy clinical sample.

Claim (Index 20):
The means of  claim 19 , wherein said treatment regimens are selected from a group consisting of therapeutics, prophylactics, exercise regimens, dietary supplementation, weight loss, surgical intervention, device implantation and exercise regimens.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 90.0
- Lexical Diversity: 1.65217
- Patent Class: 435.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12300019', '13561913', '14945200', '13504720', '13253578']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6783324780613783
- 35 USC 102 Novelty (BERT): 0.5384144417714525
- Combined Prediction Score: 0.6643406744323856
- Mean Citation Score: 303.710454
- Max Citation Score: 387.223
- Similarity Product: 275.0064023100137

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test